Literature DB >> 27251900

Centrofacial Balamuthiasis: case report of a rare cutaneous amebic infection.

Oliver H Chang1, Fan Liu2, Eleanor Knopp2,3, Atis Muehlenbachs4, Jennifer R Cope5, Ibne Ali5, Robert Thompson3, Evan George6.   

Abstract

Free-living amebae are ubiquitous in our environment, but rarely cause cutaneous infection. Balamuthia mandrillaris has a predilection for infecting skin of the central face. Infection may be restricted to the skin or associated with life-threatening central nervous system (CNS) involvement. We report a case of a 91-year-old woman, who presented with a non-healing red plaque over her right cheek. Several punch biopsies exhibited non-specific granulomatous inflammation without demonstrable fungi or mycobacteria in histochemical stains. She was treated empirically for granulomatous rosacea, but the lesion continued to progress. A larger incisional biopsy was performed in which amebae were observed in hematoxylin-eosin stained sections. These were retrospectively apparent in the prior punch biopsy specimens. Immunohistochemistry and polymerase chain reaction studies identified the organisms as Balamuthia mandrillaris. Cutaneous infection by B. mandrillaris is a rare condition that is sometimes complicated by life-threatening CNS involvement and which often evades timely diagnosis due to its rarity and nonspecific clinical manifestations. Moreover, these amebae are easily overlooked in histopathologic sections because of their small number and their resemblance to histiocytes. Dermatopathologists should be familiar with the histopathologic appearance of these organisms and include balamuthiasis and other amebic infections in the differential diagnosis of granulomatous dermatitis.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Balamuthia mandrillaris; ameba; cutaneous balamuthiasis; free living amebae; skin infections

Mesh:

Year:  2016        PMID: 27251900      PMCID: PMC5033676          DOI: 10.1111/cup.12748

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  20 in total

1.  Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement.

Authors:  Dalila Y Martínez; Carlos Seas; Francisco Bravo; Pedro Legua; Cesar Ramos; Alfonso M Cabello; Eduardo Gotuzzo
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

2.  Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.

Authors:  Francisco G Bravo; Carlos Seas
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 3.  Successful treatment of granulomatous amoebic encephalitis with combination antimicrobial therapy.

Authors:  Hideki Kato; Shigehisa Mitake; Hiroyuki Yuasa; Shigemasa Hayashi; Tatsuru Hara; Noriyuki Matsukawa
Journal:  Intern Med       Date:  2013       Impact factor: 1.271

4.  Transmission of Balamuthia mandrillaris through solid organ transplantation: utility of organ recipient serology to guide clinical management.

Authors:  A A Gupte; S N Hocevar; A S Lea; R D Kulkarni; D C Schain; M J Casey; I R Zendejas-Ruiz; W K Chung; C Mbaeyi; S L Roy; G S Visvesvara; A J da Silva; J Tallaj; D Eckhoff; J W Baddley
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

5.  Isolation and molecular characterization of Acanthamoeba and Balamuthia mandrillaris from combination shower units in Costa Rica.

Authors:  Lissette Retana-Moreira; Elizabeth Abrahams-Sandí; Alfonso Martín Cabello-Vílchez; María Reyes-Batlle; Basilio Valladares; Enrique Martínez-Carretero; José E Piñero; Jacob Lorenzo-Morales
Journal:  Parasitol Res       Date:  2014-08-19       Impact factor: 2.289

6.  Balamuthia mandrillaris from soil samples.

Authors:  Thelma H Dunnebacke; Frederick L Schuster; Shigeo Yagi; Gregory C Booton
Journal:  Microbiology       Date:  2004-09       Impact factor: 2.777

Review 7.  Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

Authors:  Govinda S Visvesvara; Hercules Moura; Frederick L Schuster
Journal:  FEMS Immunol Med Microbiol       Date:  2007-04-11

8.  Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases.

Authors:  Thomas R Deetz; Mark H Sawyer; Glenn Billman; Frederick L Schuster; Govinda S Visvesvara
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

9.  Balamuthia mandrillaris therapeutic mud bath in Jamaica.

Authors:  C D Todd; M Reyes-Batlle; J E Piñero; E Martínez-Carretero; B Valladares; J F Lindo; J Lorenzo-Morales
Journal:  Epidemiol Infect       Date:  2014-10-22       Impact factor: 4.434

10.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02
View more
  3 in total

1.  The Epidemiology and Clinical Features of Balamuthia mandrillaris Disease in the United States, 1974-2016.

Authors:  Jennifer R Cope; Janet Landa; Hannah Nethercut; Sarah A Collier; Carol Glaser; Melanie Moser; Raghuveer Puttagunta; Jonathan S Yoder; Ibne K Ali; Sharon L Roy
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

2.  Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris.

Authors:  Matthew T Laurie; Corin V White; Hanna Retallack; Wesley Wu; Matthew S Moser; Judy A Sakanari; Kenny Ang; Christopher Wilson; Michelle R Arkin; Joseph L DeRisi
Journal:  mBio       Date:  2018-10-30       Impact factor: 7.867

3.  Cutaneous balamuthiasis: A clinicopathological study.

Authors:  Patricia Alvarez; Carlos Torres-Cabala; Eduardo Gotuzzo; Francisco Bravo
Journal:  JAAD Int       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.